These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8715552)

  • 1. Progressive supranuclear palsy: managing the disabilities and providing nursing support.
    Rohs G
    Axone; 1996 Mar; 17(3):60-5. PubMed ID: 8715552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive supranuclear palsy.
    Pourfar M; Vonsattel JP
    Sci Aging Knowledge Environ; 2004 Jul; 2004(30):dn1. PubMed ID: 15282366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Learned helplessness" and the patient with progressive supranuclear palsy.
    Kube M; Wernick M; Murphy S
    Adv Clin Care; 1990; 5(3):24-7. PubMed ID: 2328072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and clinical features of progressive supranuclear palsy: a clinical study.
    Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G
    Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic dysfunction in patients with progressive supranuclear palsy.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Reichmann H; Berg D; Ziemssen T
    Mov Disord; 2008 Oct; 23(14):2083-9. PubMed ID: 18792126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
    Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
    Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pupil diameter in darkness differentiates progressive supranuclear palsy (PSP) from other extrapyramidal syndromes.
    Schmidt C; Herting B; Prieur S; Junghanns S; Schweitzer K; Globas C; Schöls L; Antoni S; Ferger D; Reichmann H; Wilhelm H; Berg D; Ziemssen T
    Mov Disord; 2007 Oct; 22(14):2123-6. PubMed ID: 17853484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. John needed all I could give.
    Sokol KM
    RN; 1999 Nov; 62(11):44-7. PubMed ID: 10640134
    [No Abstract]   [Full Text] [Related]  

  • 10. Sleep abnormalities in progressive supranuclear palsy.
    Aldrich MS; Foster NL; White RF; Bluemlein L; Prokopowicz G
    Ann Neurol; 1989 Jun; 25(6):577-81. PubMed ID: 2742360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical and epidemiological description of a series of patients diagnosed as suffering from progressive supranuclear palsy].
    Alvarez-González E; Maragoto-Rizo C; Arteche-Prior M; Pérez-Parra S; Carballo M; Alvarez-González L
    Rev Neurol; 2004 Dec 1-15; 39(11):1006-10. PubMed ID: 15597260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.
    Sixel-Döring F; Schweitzer M; Mollenhauer B; Trenkwalder C
    Sleep Med; 2009 Apr; 10(4):407-15. PubMed ID: 18945638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease.
    Cordato NJ; Halliday GM; Caine D; Morris JG
    Mov Disord; 2006 May; 21(5):632-8. PubMed ID: 16353177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Axial (neck and trunk) rigidity in Parkinson's disease, striatonigral degeneration and progressive supranuclear palsy].
    Nagumo K; Hirayama K
    Rinsho Shinkeigaku; 1996 Oct; 36(10):1129-35. PubMed ID: 8997136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
    Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
    No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative care in Parkinson's disease: implications for neuroscience nursing.
    Bunting-Perry LK
    J Neurosci Nurs; 2006 Apr; 38(2):106-13. PubMed ID: 16681291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progressive supranuclear palsy: neurological, neuropathological and neuropsychological aspects].
    Gómez-Haro C; Espert-Tortajada R; Gadea-Doménech M; Navarro-Humanes JF
    Rev Neurol; 1999 Nov 16-30; 29(10):936-56. PubMed ID: 10637844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy: a current review.
    Lubarsky M; Juncos JL
    Neurologist; 2008 Mar; 14(2):79-88. PubMed ID: 18332837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balance and eye movement training to improve gait in people with progressive supranuclear palsy: quasi-randomized clinical trial.
    Zampieri C; Di Fabio RP
    Phys Ther; 2008 Dec; 88(12):1460-73. PubMed ID: 18948373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive supranuclear palsy with wall-eyed bilateral internuclear ophthalmoplegia syndrome.
    Matsumoto H; Ohminami S; Goto J; Tsuji S
    Arch Neurol; 2008 Jun; 65(6):827-9. PubMed ID: 18541806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.